Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-09-17Clinical Trial Update: IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
The IBIS study in Italy assessing the burden of illness for schizophrenia and bipolar disorder has completed, sponsored by AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2012-09-17Clinical Trial Update: The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients [NA]
A terminated clinical trial investigating the effects of sertindole on sensory gating and cognition in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia [Phase 4]
A Phase 4 study assessed whether adding aripiprazole to clozapine can improve side effects in people with schizophrenia; the trial has compl…
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia [Phase 4]
Phase 4 trial evaluating ramelteon as an adjunct therapy in non-diabetic patients with schizophrenia and related disorders; results have bee…
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia [Phase 2]
A Phase 2 clinical trial investigating transcutaneous non-invasive vagus nerve stimulation (t-VNS) for schizophrenia has completed. The spon…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-09-12Clinical Trial Update: Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone [Phase 3]
A Phase 3 head-to-head trial compared quetiapine XR with risperidone in schizophrenia, focusing on subjective well-being and tolerability; r…
-
FDA approval · 2012-09-12FDA Approved: OLANZAPINE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for olanzapine from Jubilant Cadista Pharmaceuticals Inc., providing a generic version of the antipsyc…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: A Long-Term Study of JNS007ER in Patients With Schizophrenia [Phase 3]
A Phase 3 long-term trial of JNS007ER in schizophrenia has been completed. Results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence [Phase 2]
This clinical trial update reports a Phase 2 double-blind, controlled study of aripiprazole in patients with co-morbid schizophrenia and coc…
-
FDA approval · 2012-09-05FDA Approved: ZIPRASIDONE — Original Application (Chartwell RX, LLC)
FDA approved an original application for ziprasidone from Chartwell RX, LLC, enabling a new generic version of the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Aripiprazole Open-Label, Safety and Tolerability Study [Phase 3]
This is an open-label Phase 3 study of aripiprazole assessing safety and tolerability in schizophrenia and bipolar disorder; results were po…
-
FDA approval · 2012-08-29FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approves a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) submitted by Janssen Pharmaceuticals, extending/adjusti…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
Terminated observational study evaluating paliperidone ER in schizophrenia, focusing on economic, functional, and clinical outcomes.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Clinical Benefits of Seroquel XR in Anxiety Disorder [Phase 3]
Phase 3 update reports potential clinical benefits of Seroquel XR in anxiety disorders (with schizophrenia listed among conditions studied).
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia [NA]
A multicenter, open-label, randomized, haloperidol-controlled trial evaluating quetiapine (Seroquel) as monotherapy for agitation in patient…
-
CLINICAL_TRIALS trial_result · 2012-08-21Clinical Trial Update: Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia [Phase 3]
A long-term Phase 3 trial of lurasidone hydrochloride in chronic schizophrenia completed, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents [Phase 3]
A Phase 3 clinical trial evaluated lurasidone for the treatment of schizophrenia or schizoaffective disorder in patients switched from other…
-
CLINICAL_TRIALS research · 2012-08-16Clinical Trial Update: Internalized Stigma in Patients With Bipolar Disorder or Schizophrenia
ClinicalTrials.gov update describing a study on internalized stigma in patients with bipolar disorder or schizophrenia; the current status i…
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Improving Insight in Patients Diagnosed With Schizophrenia [NA]
This clinical trial update notes that a study examining methods to improve insight in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-08Clinical Trial Update: Family Intervention for Mental Illness and Substance Abuse [NA]
A completed clinical trial evaluating a family intervention for mental illness and substance abuse.
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]
This update reports the completion of a Phase 4 clinical trial comparing risperidone with haloperidol in patients with schizophrenia and sch…
-
FDA approval · 2012-08-03FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
FDA approval · 2012-08-02FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The U.S. FDA approved a supplemental application for Risperdal M-TAB (risperidone) submitted by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Aripiprazole in Adolescents With Schizophrenia [Phase 3]
A Phase 3 trial of aripiprazole in adolescents with schizophrenia completed. Results were posted in August 2012.
-
CLINICAL_TRIALS research · 2012-08-01Clinical Trial Update: Schizophrenia Imaging [NA]
A clinical trial update from Tel-Aviv Sourasky Medical Center on schizophrenia imaging, examining fetal differences between healthy and schi…